Diarylsulfone non-nucleoside reverse transcriptase inhibitors of

Details Diarylsulfone non-nucleoside reverse transcriptase inhibitors of Diarylsulfone non-nucleoside reverse transcriptase inhibitors of

1997-07-29

2000-05-16

Huang, Evelyn Mei

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

546166, A61K 3147, C07D21536

Patent

active

060637900

ABSTRACT:
In accordance with the present invention, there is now provided novel anti-HIV compounds of the formulae selected from the group consisting of: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1 -C.sub.4 alkyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.3 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.4 is hydrogen or halogen, R.sub.5 is hydrogen; C.sub.1 -C.sub.4 alkoxy, nitro, halogen or haloalkyl; R.sub.6 is hydrogen or nitro; R.sub.7 is hydrogen or C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.8 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.9 is hydrogen or nitro; R.sub.10 is hydrogen or halogen; R.sub.11 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.12 is hydrogen, C.sub.1 -C.sub.4 alkyl or halogen; R.sub.13 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.14 is hydrogen or halogen; R.sub.15 is hydrogen, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkyl, nitro, or halogen; R.sub.16 is hydrogen or nitro; R.sub.17 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.18 is hydrogen, C.sub.1 -C.sub.4 alkoxy, hydroxy, or halogen; R.sub.19 is hydrogen or nitro; and R.sub.20 is hydrogen or halogen and R.sub.21 is hydrogen or NO.sub.2, or a pharmaceutically acceptable salt thereof.

REFERENCES:
patent: 4505929 (1985-03-01), Markley et al.
patent: 5017610 (1991-05-01), Imaki
patent: 5278173 (1994-01-01), Davis
patent: 5308854 (1994-05-01), Hoffman, Jr. et al.
patent: 5444036 (1995-08-01), Iwasaki
patent: 5545750 (1996-08-01), Kempf et al.
patent: 5565200 (1996-10-01), Khwaja
patent: 5679695 (1997-10-01), Wassmundt
Artico et al., "Synthesis of Pyrryl Aryl Sulfones Targeted at the HIV-1 Reverse Transcriptase", Arch. Pharm. vol. 328, pp. 223-229 (1995) (Weinheim).
Kuboyama K et al. Bunseki Kagaku, 45(1), 71-6, 1996.
Chechegoeva EV et al. Zh. Org. Khim., 2 (7), 1321, 1966.
Burmistrov SI et al. Ukr. Khim. Zh., 33(2), 183-4, 1967.
Litvinenko LM et al. Zh. Obshch. Khim., 40 (4) 886-94, 1970.
Sheiko SG et al. Zh. Org. Khim., 14 (12), 2565-9, 1978.
Buckheit RW et al. Antiviral Chem. Chemother., 7(5), 243-252, 1996.
McMahon JB et al. Antimicrob. Agents Chemother., 37(4), 754-60, 1993.
Gennaro AR et al. J. Org. Chem., 36(9), 1321-4, 1971.

Affiliated with

Also associated with

Rating

Diarylsulfone non-nucleoside reverse transcriptase inhibitors of does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diarylsulfone non-nucleoside reverse transcriptase inhibitors of, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diarylsulfone non-nucleoside reverse transcriptase inhibitors of will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-259146